Reversed a judgment that a patent for a pharmaceutical product was invalid on the ground of obviousness. The Federal Circuit concluded that obviousness was not proved by clear and convincing evidence.
By submitting this form, you agree to FindLaw.com's terms. We respect your privacy.
Thank you for subscribing!